The EU has secured up to 400 million doses of AstraZeneca's experimental vaccine.
Italy is set to receive 16 million shots of the potential COVID-19 vaccine developed by British drugmaker AstraZeneca in the first months of 2021 as part of a supply deal agreed at a European Union level, a government source said. Other countries such as those in Latin America may buy vaccines through COVAX. The agency could take "days" to deliberate on whether to authorize the vaccine, F.D.A. Commissioner Dr. Stephen Hahn said in an interview with USA TODAY published Tuesday.
Moderna, Pfizer and AstraZeneca have announced trial data that showed their vaccines were highly effective.
Michael Mullette, managing director of Moderna's Canadian unit, said timing of shipments will depend in part on which countries have approved its vaccine, noting that Canada has been working to speed up the regulatory process.
The National Vaccine Institute will sign a 6-billion-dollar forward contract for Covid-19 vaccine with British-Swedish producer AstraZeneca on Friday.
Health Canada said last week that it could approve one or more vaccine early in the first quarter of 2021. In Pfizer's case, it must be kept at the ultra-cold temperature of around minus-70 degrees Celsius (minus-94 Fahrenheit).
Development of COVID-19 vaccine is still in progress. No price was given for the Chinese vaccine. In both cases, two doses have to be given, a month apart.
"And so that means we have a pathway to, not just a COVID-safe Australia, but a fully safe Australia, a return to normal", he said.
Reassuring, too, are the statements made by leaders of the world's most powerful nations when they wrapped up the Group of 20 summit on Sunday, vowing to spare no effort to protect lives and ensure affordable access to Covid-19 vaccines for all people.
Further late-stage trial results for the Oxford vaccine are forthcoming, with data from 60,000 participants in the US, Kenya, Japan and India expected later this year.